Functional Comparison for Lipid Metabolism and Intestinal and Fecal Microflora Enzyme Activities between Low Molecular Weight Chitosan and Chitosan Oligosaccharide in High-Fat-Diet-Fed Rats-Reference-Cited by-同舟云学术

Functional Comparison for Lipid Metabolism and Intestinal and Fecal Microflora Enzyme Activities between Low Molecular Weight Chitosan and Chitosan Oligosaccharide in High-Fat-Diet-Fed Rats

Published:2017-07-24 Issue:7 Volume:15 Page:234
ISSN:1660-3397
Container-title:Marine Drugs
language:en
Short-container-title:Marine Drugs

Author:

Chiu Chen-Yuan,Feng Shih-An,Liu Shing-Hwa^ORCID,Chiang Meng-Tsan

Publisher

MDPI AG

Subject

Drug Discovery,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Pharmaceutical Science

Link

http://www.mdpi.com/1660-3397/15/7/234/pdf

Reference49 articles.

1. Food consumption trends and drivers

2. Obesity and Overweighthttp://www.who.int/mediacentre/factsheets/fs311/en/

3. Diabeteshttp://www.who.int/mediacentre/factsheets/fs312/en/

4. Global and societal implications of the diabetes epidemic

5. Type 2 diabetes: principles of pathogenesis and therapy

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of low molecular weight chitosan in animal nutrition, husbandry, and health: A review;Carbohydrate Polymer Technologies and Applications;2023-12

2. Anti-Obesity Effects of Chitosan and Its Derivatives;Polymers;2023-10-01

3. Integrating omics and network pharmacology reveals the anti-constipation role of chitosan with different molecular weights in constipated mice;International Journal of Biological Macromolecules;2023-04

4. Antidiabetic Properties of Chitosan and Its Derivatives;Marine Drugs;2022-12-17

5. Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities;Pharmaceutics;2022-07-11